George Coukos
Immunology · 2001–2020
A researcher in the Science corpus: 23 papers; trusts 13 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 345 citations into it; #489 of 2,160 by trust here, #111 by citations
- Oncology — 336 citations into it; #390 of 1,698 by trust here, #149 by citations
- Biological Psychiatry — 5 citations into it
Whom George Coukos trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts George Coukos overall
Papers from George Coukos's perspective
Ordered by how strongly the researchers George Coukos trusts endorse each paper. Same corpus, a different order for every researcher.
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
- Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cells (Nature Immunology)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Modulation of tryptophan catabolism by regulatory T cells (Nature Immunology)
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
- Ido expression by dendritic cells: tolerance and tryptophan catabolism (Nature reviews. Immunology)
- Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. (Journal of Clinical Oncology)
Their papers
- The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis (2008) — 1,014 citations
- Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors (2014) — 941 citations
- Interrogating open issues in cancer precision medicine with patient-derived xenografts (2017) — 601 citations
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) — 916 citations
- High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays (2020) — 346 citations
- Cooperation between Constitutive and Inducible Chemokines Enables T-cell Engraftment and Immune Attack in Solid Tumors (2019) — 719 citations
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance (2019) — 1,924 citations
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) — 555 citations
- Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer (2015) — 1,071 citations
- Comprehensive Genomic Characterization of Long Non-Coding RNAs across Human Cancers (2015) — 606 citations
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T Cell Rejection Function in Tumors (2013) — 700 citations
- Deciphering and reversing tumor immune suppression. (2013) — 606 citations
- T Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis (2012) — 765 citations
- Prognostic Significance of Tumor-infiltrating T-cells in Ovarian Cancer: a Meta-analysis (2011) — 609 citations
- Rethinking Ovarian Cancer: Recommendations for Improving Outcomes (2011) — 1,276 citations
- Cancer immunotherapy comes of age (2011) — 3,898 citations
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells (2011) — 1,277 citations
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. (2009) — 810 citations
- Modulation of the anti-tumor immune response by complement (2008) — 761 citations
- microRNAs exhibit high frequency genomic alterations in human cancer. (2006) — 1,119 citations